VILDAZYME DM 10/100/500

VILDAZYME DM 10/100/500 contains Dapagliflozin 10 mg + Vildagliptin 100 mg (SR) + Metformin 500 mg, a triple-action therapy for comprehensive type 2 diabetes control. Dapagliflozin removes excess glucose through urine, Vildagliptin enhances insulin release after meals, and Metformin improves insulin sensitivity while reducing liver glucose production. This combination helps maintain stable blood sugar levels and supports effective long-term glycemic management.